✦ LIBER ✦

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

✍ Scribed by Robert J Lederman; Farrell O Mendelsohn; R David Anderson; Jorge F Saucedo; Alan N Tenaglia; James B Hermiller; William B Hillegass; Krishna Rocha-Singh; Thomas E Moon; MJ Whitehouse; Brian H Annex

Book ID: 117280930
Publisher: The Lancet
Year: 2002
Tongue: English
Weight: 103 KB
Volume: 359
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(02)08937-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic angiogenesis with recombinan

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomized trial

✍ R.J. Lederman; F.O. Mendelsohn; J.F. Saucedo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Design of the therapeutic angiogenesis w

Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial

✍ Robert J. Lederman; Alan N. Tenaglia; R.David Anderson; James B. Hermiller; Kris 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Angiogenesis with recombinant fibroblast

Angiogenesis with recombinant fibroblast growth factor-2 for claudication

✍ David Williams; Kim Davenport; Yih Tan 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 47 KB

Angiogenesis with recombinant fibroblast

Angiogenesis with recombinant fibroblast growth factor-2 for claudication

✍ Robert J Lederman; Brian H Annex 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 47 KB

Implications of smoking status on the re

Implications of smoking status on the response to therapeutic angiogenesis in peripheral artery disease: findings from the therapeutic angiogenesis with FGF-2 for intermittent claudication (TRAFFIC) trial

✍ Jorge F. Saucedo; Mohammed M. Moursi; R.D. Anderson; Farrell O. Mendelsohn; Jame 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 151 KB